Glycaemic indices and non-traditional biochemical cardiovascular disease markers in a diabetic population in Nigeria

Journal of the College of Physicians and Surgeons Pakistan

Volumn 21, Issue 8, 2011, Pages 455-459

  Okeoghene, Ogbera Anthonia ^a   Azenabor, Alfred ^b  

^a LAGOS STATE UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^b LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

C reactive protein; Diabetes mellitus; Glycaemic indices; Glycosylated haemoglobin; Hyperfibrinogenaemia; Microalbuminuria; Serum Uric acid

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; LIPOPROTEIN A; URIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE MARKER; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC INDEX; HUMAN; HYPERFIBRINOGENEMIA; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; URIC ACID BLOOD LEVEL;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRINOGENS, ABNORMAL; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; NIGERIA; QUESTIONNAIRES; RISK ASSESSMENT; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; URIC ACID;

EID: 80051730584     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ogbera AO. Burden of diabetic illness in an urban hospital in Nigeria. Trop Doct 2007; 37:153-4.
2. Donahue RP, Orchard TJ. Diabetes mellitus and macrovascular complications: an epidemiological perspective. Diabetes Care 1992; 15:1141-55.
3. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. Br Med J 1983; 87:867-70.
4. Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute oronary syndrome, Cardiovascular Diabetol 2006; 5:15.
5. Laakso M. Glycaemic control and the risk for coronary heart disease in patients with non insulin dependent diabetes mellitus: the Finish studies. Ann Intern Med 1996; 1:127-30.
6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and omplications Trial Research Group. N Engl J Med 1993; 329:977-86.
7. Ogbera AO. Azenabor A. Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metabol Syndr 2010, 2:24.
8. Muntner P, He J, Chen J, Fonseca M, Whelton PK. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol 2004; 14:686-95.
9. Fonseca V, Desouza C, Asnani S, Jialal I. Nontraditional risk factors for cardiovascular disease in diabetes. Endocr Rev 2004; 26:153-75.
10. Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, et al. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between ipoproteins and thrombosis. Blood 2001; 98:2980-7.
11. Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, et al. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2006, 5:27.
12. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of the metabolic syndrome in women and men. Metabolism 2008; 57:845-52.
13. Bruno G, Cavallo-Perin P, Bargero G, Borra MB, D'Errico N, Paqano G. Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-ependent diabetes mellitus. Ann Intern Med 1996; 125:653-657.
14. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB, et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 11:1370-6. Epub 2005 Feb 28.
15. Hom FG, Ettinger B, Lin MJ. Comparison of serum fructosamine vs glycohemoglobin as measures of glycemic control in a large diabetic population. Acta Diabetol 1998; 35:48-1.
16. Bouma M, Dekker JH, van Eijk JT, Schellevis FG, Kriegsman DM, Heine RJ. Metabolic control and morbidity of Type 2 diabetic patients in general practice network. Fam Pract 990; 16:402-6.
17. Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, et al. Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition. Diabetes Care 2001; 24:1240-7.
18. King DE, Mainous AG, Buchanan TA, Pearson WS. C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 2003; 26:1535-9.
19. Lima LM, Carvallo MC, Soares L, Sabino P, Fernandes AP, Novelli BA, et al. High sensitivity C-reactive protein in subjects with type 2 diabetes mellitus and/or high blood ressure. Arq Bras Endocrinol Metab 2007; 51:956-60.
20. Bengtsson C, Lapidus L, Stendahal C, Waldenstrom J. Hyperuricemia and risk of cardiovascular disease and overall death. Acta Med Scand 1988; 224:549-55.
21. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27:813-23.
22. Chan JC, Yeung VTF, Cheung CK. Swaminathan R, Cockram CS. The inter-relationships between albuminuria, plasma albumin concentration and indices of glycaemic control in non-insulindependent diabetes mellitus. Clin Chim Acta 1992; 210:179-85.
23. Lee AJ, Lowe GD, Woodward M, Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J 1993; 69:338-42.
24. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am Heart J 1990; 20:672-6.
25. Mahmood IH. Serum uric acid concentration in patients with type 2 diabetes mellitus during diet or glibenclamide therapy. Pak J Med Sci 2007; 23:361-5.